BDBM505753 US11066414, Compound 398::tert-butyl 4-(4-(((8-chloro-4-((3- chloro-4-fluorophenyl)amino)-3- cyanoquinolin-6-yl)amino)(1- methyl-1H-1,2,3-triazol-4- yl)methyl)-1H-1,2,3-triazol-1- yl)piperidine-1-carboxyl ate

SMILES CN1NNC(=C1)C(Nc1cc(Cl)c2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2c1)C1=CN(NN1)C1CCN(CC1)C(=O)OC(C)(C)C

InChI Key InChIKey=GLTPPVSSFKZNFA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 505753   

TargetEpidermal growth factor receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM505753(tert-butyl 4-(4-(((8-chloro-4-((3- chloro-4-fluoro...)
Affinity DataIC50: 435nMAssay Description:EGFR activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, EGFR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2021
Entry Details
US Patent